Weill Cornell Medical College has received a major $7.6 million award from the National Heart, Lung, and Blood Institute (NHLBI) to establish a consortium that will support three clinical trials on new ways to help patients with cardiopulmonary disease make beneficial changes in their behavior.

An article just published in the Journal of Clinical Investigation sets out the results of an investigation into the immune defects of some 60 persons with immune-mediated diabetes, the most common form of type 1 diabetes. The study delineates precisely what predisposes a person to this condition, and the latest, best measures for diagnosis, prediction, and therapy. Above all, the authors suggest a new strategy for combating the disease: stimulate rather than suppress the patient's immune system.

The latest research in the conditions known as "persistent vegetative state" and "minimally conscious state" will be presented by Dr. Nicholas Schiff, Assistant Professor of Neurology and Neuroscience at Weill Cornell Medical College, at the meeting in Boston today of the American Association for the Advancement of Science (AAAS).

The NewYork-Presbyterian Hospital today announced plans to establish the Jay Monahan Center for Gastrointestinal Health at the Hospital's NewYork Weill Cornell Medical Center site. Opening in early 2004, the Center -- providing all services under one roof -- will be specifically and comprehensively dedicated to gastrointestinal health, from detection and treatment to education, prevention, and research.

Dr. Gerald Loughlin, a leading authority on children's respiratory disorders, has joined NewYork Weill Cornell Children's Hospital of NewYork-Presbyterian as the newly appointed Pediatrician-in-Chief.

A new study from Weill Cornell Medical College suggests possible approaches to preventing scar formation in heart muscle when there is cardiac valvular disease, and thus reducing both the risk of heart failure and the need for valve operations.

Levels of a pivotal signal processor in the brain are reduced significantly in people with schizophrenia, a study by scientists at Weill Cornell Medical College, The Rockefeller University, and University of California at Irvine (UCI) has found.

Mindy S. Miller, a development professional with over 25 years of experience at leading New York institutions and companies, has been named Director of the Capital Campaign at Weill Cornell Medical College.